THE EFFECT OF LENALIDOMIDE ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES: RESULTS FROM THE MDS-005 TRIAL

被引：0

作者：

Santini, V. ^{[1
]}

Almeida, A. ^{[2
]}

Giagounidis, A.

Bartiromo, C. ^{[3
]}

Hoenekopp, A. ^{[4
]}

Guo, S. ^{[5
]}

Beach, C. ^{[6
]}

Altincatal, A. ^{[5
]}

Wu, C. ^{[7
]}

Skikne, B. ^{[6
]}

Zhong, J. ^{[7
]}

Hu, H. ^{[3
]}

Fenaux, P. ^{[8
]}

机构：

[1] Univ Florence, AOU Careggi, Dipartimento Med Sperimentale & Clin, Florence, Italy

[2] Inst Portugues Oncol Francisco Gentil, Dept Hematol, Lisbon, Portugal

[3] Celgene Corp, Market Access & Outcomes Res, Summit, NJ USA

[4] Celgene Int, Hematol & Oncol, Boudry, Switzerland

[5] Evidera, Lexington, MA USA

[6] Celgene Corp, Hematol & Oncol, Summit, NJ USA

[7] Celgene Corp, Biostat, Summit, NJ USA

[8] Univ Paris 07, Hop St Louis, Serv Hematol Seniors, Paris, France

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P242

引用

页码：68 / 68

页数：1